saquinavir (Q422654)

(2S)-N-[(2S,3R)-4-[(3S,4aS,8aR)-3-[(tert-butylamino)-oxomethyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[[oxo(2-quinolinyl)methyl]amino]butanediamide

SAQUINAVIR (English)

19 October 2016

1 reference

based on heuristic

inferred from InChIKey

chemical formula

C₃₈H₅₀N₆O₅

1 reference

SAQUINAVIR (English)

19 November 2016

CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O

1 reference

SAQUINAVIR (English)

19 November 2016

CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@H]([C@H](CC3=CC=CC=C3)NC(=O)[C@H](CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O

1 reference

https://www.whocc.no/atc_ddd_index/?code=J05AE01

SAQUINAVIR (English)

19 November 2016

1.8 gram

route of administration

oral administration

1 reference

reference URL

active ingredient in

Fortovase

1 reference

European Medicines Agency product number

EMEA/H/C/000178

reference URL

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000178/human_med_000799.jsp

22 March 2017

1 reference

14 February 2018

World Health Organisation international non-proprietary name

saquinavir (English)

1 reference

saquinavir (English)

medical condition treated

19 October 2016

1 reference

human immunodeficiency virus infectious disease

13 December 2016

1 reference

significant drug interaction

13 December 2016

bosentan

1 reference

High-priority drug–drug interactions for use in electronic health records

carbamazepin

1 reference

High-priority drug–drug interactions for use in electronic health records

rifabutin

1 reference

High-priority drug–drug interactions for use in electronic health records

rifampicin

1 reference

High-priority drug–drug interactions for use in electronic health records

rifapentine

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

voriconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

venlafaxine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

rhabdomyolysis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rosuvastatin

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

retroperitoneal hemorrhage

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

kidney failure

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

cholestasis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cyclosporine

paresthesia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

posaconazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Ketoconazole

1 reference

established

A reference set of clinically relevant adverse drug-drug interactions

atorvastatin

rhabdomyolysis

1 reference

A reference set of clinically relevant adverse drug-drug interactions

atorvastatin

muscular disease

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fosphenytoin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Saquinavir

last update

1 September 2017

subject has role

HIV protease inhibitors

2 references

5 March 2018

Medical Subject Headings

MeSH descriptor ID

D019258

cytochrome P-450 CYP3A inhibitors

15 March 2018

1 reference

CAS COVID-19 Anti-Viral Candidate Compounds

Medical Subject Headings

15 March 2018

0 references

1 reference

1 reference

Saquinavir

0 references

catalog

0 references

Identifiers

InChI

InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1

1 reference

SAQUINAVIR (English)

19 November 2016

2 references

SAQUINAVIR (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

127779-20-8

2 references

saquinavir (English)

19 November 2016

https://commonchemistry.cas.org/detail?cas_rn=127779-20-8

9 April 2021

1 reference

Saquinavir (English)

19 November 2016

2 references

SAQUINAVIR (English)

19 November 2016

Reaxys registry number

5469491

1 reference

saquinavir (English)

19 October 2016

mapping relation type

2 references

SAQUINAVIR (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1

1 reference

SAQUINAVIR (English)

19 November 2016

2 references

inferred from InChIKey

1 reference

MassBank accession ID

MSBNK-Waters-WA001494

0 references

MSBNK-Waters-WA001495

0 references

MSBNK-Waters-WA001496

0 references

MSBNK-Waters-WA001497

0 references

HSDB ID

7161

1 reference

Hazardous Substances Data Bank

28 October 2019

SAQUINAVIR (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

Guide to Pharmacology Ligand ID

Saquinavir (English)

publication date

17 November 2015

4813

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

4813

saquinavir (English)

19 November 2016

Saquinavir

0 references

0 references

0 references

1 reference

saquinavir (English)

19 November 2016

1 reference

Human Metabolome Database ID

0 references

2 references

saquinavir (English)

19 November 2016

MedlinePlus drug identifier

a696001

0 references

PatientsLikeMe treatment ID

saquinavir

0 references

NIAID ChemDB ID

000640

1 reference

imported from Wikimedia project

1 reference

saquinavir (English)

19 November 2016

0 references

1 reference

1 reference

electronic Essential Medicines List medicine ID

saquinavir (English)

19 October 2016

0 references

489

0 references

Encyclopædia Britannica Online ID

topic/saquinavir

subject named as

saquinavir

0 references

1 reference

28 October 2013

Interlingual Index ID

0 references

1 reference

9 July 2020

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

1C6Z (English)

19 October 2016

1 reference

3D1Y (English)

19 October 2016

1 reference

3S56 (English)

19 October 2016

1 reference

3TKG (English)

19 October 2016

1 reference

4Q5M (English)

19 October 2016

1 reference

3NDT (English)

19 October 2016

1 reference

5KR2 (English)

19 October 2016

1 reference

3TL9 (English)

19 October 2016

1 reference

2NNP (English)

19 October 2016

1 reference

2NNK (English)

19 October 2016

1 reference

3PWR (English)

19 October 2016

1 reference

3PWW (English)

19 October 2016

1 reference

3OXC (English)

19 October 2016

1 reference

5KQX (English)

19 October 2016

1 reference

3N3I (English)

19 October 2016

1 reference

3EKQ (English)

19 October 2016

1 reference

2NMZ (English)

19 October 2016

1 reference

2NMY (English)

19 October 2016

1 reference

3CYX (English)

19 October 2016

1 reference

3UFN (English)

19 October 2016

1 reference

3D1X (English)

19 October 2016

1 reference

4QGI (English)

19 October 2016

1 reference

3K4V (English)

19 October 2016

1 reference

3NDU (English)

19 October 2016

1 reference

3EL4 (English)

19 October 2016

1 reference

1HXB (English)

19 October 2016

1 reference

1FB7 (English)

19 October 2016

1 reference

inferred by common MeSH mappings on source and on Wikidata

saquinavir (English)

19 November 2016

1 reference

25 May 2023

0 references

0 references

WordNet 3.1 Synset ID

04300746-n

1 reference